HealthEquity, Inc. $HQY is Ashford Capital Management Inc.’s 10th Largest Position

Ashford Capital Management Inc. cut its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 1.9% in the first quarter, HoldingsChannel reports. The firm owned 266,481 shares of the company’s stock after selling 5,242 shares during the period. HealthEquity accounts for about 2.8% of Ashford Capital Management Inc.’s holdings, making the stock its 10th biggest holding. Ashford Capital Management Inc.’s holdings in HealthEquity were worth $22,270,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Acumen Wealth Advisors LLC purchased a new stake in HealthEquity in the fourth quarter valued at $27,000. Caitong International Asset Management Co. Ltd raised its stake in shares of HealthEquity by 1,723.5% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock valued at $28,000 after buying an additional 293 shares during the last quarter. Aster Capital Management DIFC Ltd acquired a new position in shares of HealthEquity in the 4th quarter valued at about $28,000. Leonteq Securities AG lifted its holdings in shares of HealthEquity by 159.9% in the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after buying an additional 235 shares during the period. Finally, Torren Management LLC purchased a new stake in shares of HealthEquity in the fourth quarter worth about $40,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts recently commented on the company. KeyCorp reaffirmed an “overweight” rating on shares of HealthEquity in a report on Tuesday, May 26th. Wells Fargo & Company set a $111.00 price objective on HealthEquity in a research report on Monday, June 1st. BTIG Research upped their price objective on HealthEquity from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Friday. Royal Bank Of Canada raised their price objective on shares of HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research note on Wednesday, June 3rd. Finally, Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday. Eleven research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $110.93.

Insiders Place Their Bets

In other news, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total value of $219,510.00. Following the sale, the director owned 19,733 shares in the company, valued at $1,775,970. This trade represents a 11.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction dated Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the sale, the executive vice president directly owned 59,113 shares of the company’s stock, valued at $5,615,735. This represents a 5.05% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 17,905 shares of company stock worth $1,651,280. Company insiders own 1.60% of the company’s stock.

HealthEquity Stock Performance

Shares of HQY stock opened at $99.05 on Tuesday. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.46. HealthEquity, Inc. has a 12-month low of $72.76 and a 12-month high of $105.96. The business’s 50 day moving average is $90.53 and its two-hundred day moving average is $84.90. The company has a market capitalization of $8.28 billion, a P/E ratio of 37.10, a P/E/G ratio of 1.59 and a beta of 0.21.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.13. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity’s revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Analysts expect that HealthEquity, Inc. will post 3.92 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.